All content for DDN Dialogues is the property of Drug Discovery News and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
DDN Dialogues is a new podcast from Drug Discovery News exploring the stories behind the latest advances in drug discovery research.
From warhead to cancer-killer, the quest for more actinium-225
DDN Dialogues
28 minutes 52 seconds
1 year ago
From warhead to cancer-killer, the quest for more actinium-225
Actinium-225 is a radioactive isotope that kills cancer cells with a burst of alpha particles, but it was difficult to make enough of it — until now.
https://www.drugdiscoverynews.com/from-warhead-to-cancer-killer-the-quest-for-more-actinium-225-15934
DDN Dialogues
DDN Dialogues is a new podcast from Drug Discovery News exploring the stories behind the latest advances in drug discovery research.
